NewsIn memory
What Martin Amis's Story Can Help Us Understand About Esophageal Cancer
The British novelist died in 2023 of esophageal cancer. Here is what that diagnosis means, explained calmly and simply.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What was reported
Martin Amis was a British novelist, known for Money, London Fields, and The Information. NPR reported that he died at his home in Lake Worth, Florida, of esophageal cancer. He was 73.
BBC News reported the same, citing the New York Times quoting his wife, the writer Isabel Fonseca. The date was 19 May 2023.
BBC also noted that his close friend the journalist Christopher Hitchens died of the same cancer in 2011.
That is the record. This page does not go beyond it, and the rest is about the disease, which most people know very little about.
The organ, and two different cancers
The esophagus is the hollow, muscular tube that moves food and liquid from the throat to the stomach. Its wall has several layers: a mucous membrane, muscle, and connective tissue.
Esophageal cancer starts on the inside lining and grows outward through the other layers. That geometry is why it is often advanced by the time it causes trouble.
Two types account for most cases, and NCI treats them almost as separate diseases.
Squamous cell carcinoma forms in the thin, flat cells lining the inside of the esophagus. It is found most often in the upper and middle parts.
Adenocarcinoma starts in glandular cells, the ones that make mucus. It usually forms in the lower esophagus, near the stomach.
Our page on esophageal cancer goes through how each is staged and treated.
Different causes for each type
This is where the split matters most, because the risk factors barely overlap.
For squamous cell carcinoma, NCI names smoking and heavy drinking. Studies show the risk is raised in people who do both, and lower in people who use neither.
For adenocarcinoma, the main driver is gastroesophageal reflux disease. GERD is when stomach contents, including acid, flow back up into the lower esophagus.
Long-standing reflux irritates the lining. Over time the cells there can be replaced by abnormal ones, a condition called Barrett esophagus. Those abnormal cells may later become adenocarcinoma. NCI notes that obesity combined with GERD raises the risk further.
There is also a medicine angle. Drugs that relax the muscle ring at the bottom of the esophagus make reflux more likely.
NCI mentions that some studies suggest nonsteroidal anti-inflammatory drugs may lower squamous cell risk. It attaches an immediate caution: NSAIDs raise the risk of heart attack, heart failure, stroke, gastrointestinal bleeding, and kidney damage. Our page on alcohol and cancer covers that pathway.
When to get checked
NCI's list is short and the first item does most of the work:
- Painful or difficult swallowing
- Weight loss
- Pain behind the breastbone
- Hoarseness and cough
- Indigestion and heartburn
- A lump under the skin
Difficulty swallowing is the symptom to act on. Food sticking, or a sense that it is going down slowly, is not a normal part of aging and is not something to adapt around by cutting food smaller.
Heartburn is trickier, because it is extremely common and usually harmless. What matters is heartburn that is severe, daily, and long-running. That pattern is the one linked to Barrett esophagus, and it is worth raising rather than managing indefinitely with over-the-counter antacids.
There is no routine screening test
NCI states this plainly. There is no standard or routine screening test for esophageal cancer.
Several approaches are used or studied. Esophagoscopy passes a thin lighted tube down the throat to look at the lining. Biopsies taken from several areas of the lower esophagus can detect early Barrett esophagus, and NCI notes this may be used in people who have risk factors for it. Brush cytology collects cells with a brush during that procedure. Balloon cytology uses a swallowed balloon that is inflated and pulled out. Chromoendoscopy sprays a dye that stains suspicious areas.
The distinction matters. None of this is population screening. It is targeted checking of people already known to be at higher risk, and who qualifies is a decision for a clinician who knows the history. Our page on cancer diagnosis explains how a biopsy result is read.
The numbers, and what they show about timing
An American Cancer Society projection, published by SEER, puts 2026 at 22,530 new esophageal cancers in the United States and 16,290 deaths. Survival is measured rather than projected, and it is NCI's number: 22.2 percent at five years across all stages for cases from 2016 to 2022.
By stage, it was 48.6 percent when the cancer was still confined to the esophagus, 29.1 percent once it reached nearby lymph nodes, and 5.3 percent once distant.
The distribution is the problem. Only 19 percent are found while localized. Thirty-nine percent are already distant.
These are group figures covering both cell types, all ages, and years of changing treatment. They describe a population, not any individual.
What this story cannot tell you
A death notice reports a cause. It does not report a cell type, a stage, a treatment plan, or a timeline, and none of that was made public here.
Two people dying of the same named cancer also does not mean they had the same disease. Squamous cell carcinoma and adenocarcinoma differ in where they start, what causes them, and how they are treated.
What is generalizable is smaller and more useful. Trouble swallowing deserves an appointment. Severe daily heartburn over years deserves a conversation about Barrett esophagus. Neither of those requires anyone famous to have died first.
Sources
- NPR, Martin Amis, British author of era-defining novels, dies at 73 — https://www.npr.org/2023/05/20/1177366085/martin-amis-british-author-dead
- BBC News, Martin Amis: Celebrated British novelist dies aged 73 — https://www.bbc.com/news/entertainment-arts-65660768
- NCI, What Is Esophageal Cancer? — https://www.cancer.gov/types/esophageal/what-is-esophageal-cancer
- NCI, Esophageal Cancer Symptoms — https://www.cancer.gov/types/esophageal/symptoms
- NCI, Esophageal Cancer Causes, Risk Factors, and Prevention — https://www.cancer.gov/types/esophageal/causes-risks-prevention
- NCI, Esophageal Cancer Screening — https://www.cancer.gov/types/esophageal/screening
- SEER Cancer Stat Facts, Esophageal Cancer — https://seer.cancer.gov/statfacts/html/esoph.html
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Esophageal cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.